(Q43201541)

16 November 2017

title

Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy (English)

1 reference

16 November 2017

1 reference

9

Anthony V D'Amico

1 reference

16 November 2017

Amy M Dosoretz

1

1 reference

16 November 2017

Ming-Hui Chen

2

1 reference

16 November 2017

Sharon A Salenius

3

1 reference

16 November 2017

Rudolf H Ross

4

1 reference

16 November 2017

Daniel E Dosoretz

5

1 reference

16 November 2017

Michael J Katin

6

1 reference

16 November 2017

Constantine Mantz

7

1 reference

16 November 2017

Bruce M Nakfoor

8

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

16 November 2017

1 reference

16 November 2017

volume

116

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

837-842

1 reference

Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

National practice patterns and time trends in androgen ablation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24750

7 January 2021

Identifiers

DOI

10.1002/CNCR.24750

1 reference

16 November 2017

1 reference